GOLDEN-EURO
13.4.2021 17:31:13 CEST | Business Wire | Pressemeddelelse
Champagnen flyder, og fejringen er godt undervejs i Golden Euro-casinoet, efter en heldig spiller ramte jackpotten og landede en monstergevinst på 3.746.291 €.
Spillerens gevinst blev udløst på Realtime Gamings enormt populære spillemaskine Aztec Millions og er den største gevinst nogensinde, der er blevet registreret på det progressive jackpotspil og hos Golden Euro.
Den 49-årige spiller foretog en indbetaling med kreditkort på 27 € for at starte sin session og for at få Golden Euros højtelskede 50 % indbetalingsmatchbonus, hvilket gave hende derfor 54 € at spille med.
Men selve gevinsten kom fra en lille indsats på blot 5 €, som hun foretog på sin smartphone - efterhånden som hjulene stoppede og jackpotten blev udløst, blev spilleren øjeblikkeligt millionær.
Adrian Berger fra Golden Euro Casino udtalte: "Vi er superglade for, at en af vores spillere landende den største jackpotgevinst nogensinde på Realtime Gamings Aztec Millions.
"Jeg talte med spilleren kort tid efter at have bekræftet hendes gevinst, og hun var i den syvende himmel, selvom det faktum, at hun nu er multimillionær, endnu ikke er gået helt op for hende.
"Disse gevinster er lige præcis, hvad Golden Euro handler om – vi vil gerne give vores spillere en sjov og underholdende online casinooplevelse med livsændrende gevinster, der kun er ét spin væk.
"Jeg vil endnu en gang lykønske vores heldige spiller, og jeg glæder mig til at annoncere flere store vindere og jackpotvindere hos Golden Euro i de kommende måneder."
Aztec Millions-jackpotten er atter på højkant og har allerede rundet over 1 million euro, så husk at prøve lykken og se, om du bliver den næste Golden Euro-millionær.
Jackpotværdien stiger hurtigt, fordi det er en progressiv netværksjackpot, hvilket betyder, at alle spillere, som spiller spillet på tværs af alle de casinoer, som tilbyder spillet, bidrager til jackpottens samlede sum.
Aztec Millions kan spilles på Golden Euro via download, øjeblikkeligt spil og i mobilens webbrowser.
Golden Euro Casino blev grundlagt i 2012 og er siden blevet en af de mest populære sider takket være sit fantastiske udvalg af spil, generøse bonusser og venlige kundesupport.
SLUT
Afsenders bemærkning:
Om Golden Euro Casino:
https://www.goldeneuro.com/en/
Se kildeudgaven på businesswire.com: https://www.businesswire.com/news/home/20210413005871/da/
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
Galderma Announces Triple Approval of New State-of-the-Art Restylane® Syringe in the EU, the U.S., and Canada, Reaffirming the Company’s Position at the Forefront of Injectable Aesthetics25.2.2026 07:00:00 CET | Press release
Regulatory authorities in the European Union (EU), the United States (U.S.), and Canada have approved a new state-of-the-art Restylane®syringe for use with a range of Restylane NASHA® lidocaine products in multiple indications in the face and in the hands1-3 Developed in collaboration with aesthetic practitioners, its innovative ergonomic design features a cushioned finger grip and thumb rest, to improve practitioner experience through better injection comfort and control, helping them deliver consistently premium results 4-7 The syringe’s carton packaging is the first in the industry to be made from 100% recyclable paper, and reaffirms Galderma’s commitment to sustainability and environmental responsibility 8 These approvals demonstrate Galderma’s strong heritage in Injectable Aesthetics, and its commitment to continuing to drive innovation in the field Galderma (SIX: GALD), today announced that regulatory authorities in the EU, the U.S., and Canada have approved a new state-of-the-ar
Azafaros Announces Publication of Preclinical Efficacy Data with Nizubaglustat in GM2 Gangliosidosis25.2.2026 07:00:00 CET | Press release
Preclinical proof-of-concept data in GM2 gangliosidosis demonstrated survival benefit, functional improvement and target engagementResults are published in the 7 January issue of the Journal of Inherited Metabolic DiseaseNizubaglustat is currently in Phase 3 registrational studies in GM1/GM2 gangliosidoses and Niemann-Pick type C disease (NPC) Azafaros, a company aiming to become a leader in lysosomal storage disorders (LSDs), focused on addressing especially neurological symptoms, today announced the publication of proof-of-concept preclinical data with its lead product, nizubaglustat, in GM2 gangliosidosis. The data, published in the 7 January issue of the Journal of Inherited Metabolic Disease in collaboration with the laboratory of Dr. Jagdeep Walia, Department of Pediatrics, Queen's University, Kingston, Canada, reinforce nizubaglustat’s potential to address unmet needs in rare LSDs and build on existing preclinical and clinical evidence. The preclinical study tested nizubaglustat
Verdict Expected Soon in Klarna’s $8.3 Billion Antitrust Lawsuit Against Google24.2.2026 19:09:00 CET | Press release
PriceRunner v. Google: Sweden’s Largest-Ever Civil Damages Claim Reaches Decision Stage; Klarna Provides Investor Update Klarna Group plc (NYSE: KLAR) announces that the Patent and Market Court of Sweden (Patent- och marknadsdomstolen) is expected to deliver its verdict on April 15, 2026 in the antitrust damages proceedings brought by Klarna’s subsidiary PriceRunner International AB against Google LLC and Google Ireland Limited. The trial, which ran from October 20 to December 19, 2025, concerned PriceRunner’s claim for approximately $8.3 billion in damages — the largest civil damages claim ever filed in a Swedish court. The Case The claim arises from Google’s abuse of dominance in online comparison shopping, as established by the European Commission in a binding 2017 decision and upheld without reservation by the Court of Justice of the European Union in September 2024. PriceRunner alleges that Google systematically demoted competing price comparison services in its search results whi
INRIX Announces New Generation of AI Traffic Products: Helping to Improve Safety, Reduce Congestion, and Enhance Mobility Operations24.2.2026 16:49:00 CET | Press release
New generative AI capabilities, enhanced incident detection, and expanded customer deployments mark a major evolution of the INRIX Traffic product family INRIX, a global leader in transportation data and analytics, today announced a major expansion of its Trafficfamily of products, delivering innovativeAI-driven capabilities to help transportation agencies and logistics organizations move from reactive traffic management to proactive, safety-focused and efficient operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224267928/en/ INRIX introduces expanded automation, generative AI capabilities, enhanced incident detection, and continuous analytics. Over twenty years ago, INRIX commercialized the first system to use GPS data to create real-time traffic information. In 2019, INRIX launched AI Traffic – the world's first traffic platform to leverage deep learning models and AI to improve the quality and analysis globall
Check Point and ControlPlane Partner to Help Enterprises Securely Scale AI and Accelerate Agentic Innovation24.2.2026 15:30:00 CET | Press release
ControlPlane, a specialist AI Security and DevSecOps consultancy, and Check Point Software Technologies Ltd., a pioneer and global leader in cyber security solutions, today announced a strategic collaboration to help enterprises securely adopt Large Language Models (LLMs) and agentic AI systems at scale. The partnership delivers a comprehensive, regulator-ready security framework designed to reduce risk, protect sensitive data, and enable organizations to move confidently from AI experimentation to production deployment. By combining Check Point’s AI-native threat prevention platform with ControlPlane’s deep expertise in cloud native architectures and DevSecOps, enterprises can operationalize AI securely without slowing innovation. As organizations advance AI initiatives beyond pilots, they face a growing “AI readiness gap.” Emerging threats such as prompt injection, unauthorized access, data leakage, and model misuse introduce risks that traditional security controls were not built to
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum